Cite Filings / ACAD / 0000950170-24-056077

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

ACADIA PHARMACEUTICALS INC Filed 2024-05-09 Acc 0000950170-24-056077

Documents 1

10-Q Quarterly Report , acad-20240331.htm

Around this filing

2024-08-07 10-Q Quarterly Report
2024-05-09 10-Q Quarterly Report
2024-05-08 8-K Results of operations
2024-05-03 4 EVP, COO, HEAD OF COMMERCIAL sold 3,477 shares at $16.94 ($58,900)
2024-05-03 4 EVP, CHIEF FINANCIAL OFFICER sold 3,503 shares at $16.94 ($59,341)
2024-05-03 4 PRINCIPAL ACCOUNTING OFFICER sold 1,326 shares at $16.94 ($22,462)
2023-11-03 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading acad-20240331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…